Salix Pharmaceuticals to Present at Two Investment Conferences in November

  Salix Pharmaceuticals to Present at Two Investment Conferences in November

Piper Jaffray Healthcare Conference 2012

Business Wire

RALEIGH, N.C. -- November 07, 2012

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company
will present at two investment conferences during November 2012. Information
regarding these conferences is provided below:

2012 Credit Suisse Annual Health Care Conference
Phoenix, AZ    Wednesday, November 14   5:00 p.m. ET
                                            
24^th Annual Piper Jaffray Healthcare Conference
New York, NY     Tuesday, November 27       9:00 a.m. ET

Interested parties can access a live audio web cast of the presentation at
http://www.salix.com. A replay of the presentation will be available at the
same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina,
develops and markets prescription pharmaceutical products for the treatment of
gastrointestinal diseases. Salix’s strategy is to in-license late-stage or
marketed proprietary therapeutic drugs, complete any required development and
regulatory submission of these products, and market them through the Company’s
gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol
“SLXP”.

For more information, please visit our Website at www.salix.com or contact the
Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook
(www.facebook.com/SalixPharma). Information on our Twitter feed, Face book
page and web site is not incorporated in our SEC filings.

Contact:

Salix Pharmaceuticals, Ltd.
Adam C. Derbyshire, 919-862-1000
Executive Vice President
and Chief Financial Officer
or
G. Michael Freeman, 919-862-1000
Associate Vice President, Investor Relations
and Corporate Communications
 
Press spacebar to pause and continue. Press esc to stop.